A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Eligible patients diagnosed by a health-care provider with obesity alone or along with obstructive sleep apnea ... to pay for Zepbound themselves and are enrolled in Medicare or employer ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.

Most insurance plans, including Medicare, cover CPAP machines ... the weight-loss medication tirzepatide (Zepbound) to treat moderate to severe sleep apnea in adults with obesity, to be used ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

Net prices of tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic ... such as osteoarthritis and obstructive sleep apnea, the latter of which tirzepatide was approved for in December.

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity ... obesity medications for ...

Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...